A unique partnership will offer an opportunity for patients to attain breakthrough cancer pain medication in the retail setting. ProStakan—the manufacturer of Abstral, a fentynal immediate-release transmucosal tablet—has leveraged RelayHealth’s pharmacy network and McKesson Specialty Care Solutions’ experience in administering risk mitigation and management strategies (REMS) programs to make the agent more readily available for patients.
This new connectivity platform allows for the implementation of the REMS program without disrupting pharmacy workflow. ? RelayHealth’s technology uses “real-time, electronic dispensing ‘triggers’ via the network to verify enrollment of the prescriber and pharmacy, and support patient enrollment and verification,” according to ProStrakan.